Richard B. Wilber - Concepedia

Concepedia

Author

Richard B. Wilber

Bristol-Myers Squibb (United States)

Also Known As

R B Wilber, R Wilber, R. B. Wilber, R. Wilber, R.B. Wilber, Richard B. Wilber, Richard Wilber

38

Publications

4.4K

Citations

18

H-Index

46

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)University of Santo Tomas National Cheng Kung University University of Michigan

RB

About

Richard B. Wilber is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	419
2	Immunology	5	5	125
3	Health Sciences	3	3	106
4	Biochemistry	1	1	14
5	Emergency Medicine	1	1	49

Richard B. Wilber

×

23

Publications

4.4K

Citations

18

H-Index

	Year	Citations
A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B Ting‐Tsung Chang, Robert G. Gish, Robert de Man, New England Journal of Medicine	2006	1.4K
Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B Ching‐Lung Lai, Daniel Shouval, Anna S. Lok, New England Journal of Medicine	2006	1.2K
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy # Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick, Hepatology	2009	810
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures Margaret Johnson, Beatriz Grinsztejn, Claudia Rodríguez, AIDS	2005	249
Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B Nancy Leung, Hie‐Won Hann, Jose D. Sollano, Hepatology	2008	181
20 ENTECAVIR MAINTAINS A HIGH GENETIC BARRIER TO HBV RESISTANCE THROUGH 6 YEARS IN NAIVE PATIENTS Daniel J. Tenney, Kevin A. Pokornowski, R.E. Rose, Journal of Hepatology NeurovirologyViral HepatitisImmunologyAntiviral TherapyResistance Mutation (Virology)	2009	65
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration Rashmi H. Barbhaiya, Umesh Shukla, Carol Gleason, Antimicrobial Agents and Chemotherapy Tissue PenetrationElimination Half-lifeBioanalysisSkin Blister FluidMedicine	1990	55
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures Margaret Johnson, Beatriz Grinsztejn, Claudia Rodríguez, AIDS Cover Date 29Typographical ErrorsVolume 19MedicineStatistics	2005	49
Phase I study of multiple-dose cefprozil and comparison with cefaclor Rashmi H. Barbhaiya, Umesh Shukla, Carol Gleason, Antimicrobial Agents and Chemotherapy Drug SafetyTherapeutic Drug MonitoringHealth SciencesPharmacological StudyMedicine	1990	42
Chemoprophylaxis for Pneumocystis carinii Pneumonitis Richard B. Wilber American journal of diseases of children Medicinal ChemistryHealth SciencesAntimicrobial StewardshipMedicineChildhood Cancer Patients	1980	41

Page 1